Skip to content
Aminoscope
Interactive tool

GLP-1 dose ladders

The titration schedule for each major GLP-1 medication, step by step — read straight from the FDA prescribing information. Pick a drug to see how its dose climbs from the starting dose to maintenance, and why it’s done slowly.

Wegovy

semaglutide · Weight management

Step the dose up gradually — each level is held for the labeled interval before increasing, to improve tolerability.

  1. Weeks 1–4
    0.25 mg
  2. Weeks 5–8
    0.5 mg
  3. Weeks 9–12
    1 mg
  4. Weeks 13–16
    1.7 mg
  5. Week 17+
    2.4 mg· maintenance range
Route
Subcutaneous · once weekly
Maintenance
2.4 mg once weekly
Maximum dose
7.2 mg once weekly (current label)
Indication
Weight management

Source: Wegovy FDA label (DailyMed) ↗

How to read this

Each rung is a dose level, held for the interval the label specifies (usually four weeks) before the next increase. The starting dose exists to let your gut adjust — it is not where the drug does most of its work. This is a reference, not an instruction: your prescriber may titrate more slowly, pause a step, or stop at a lower maintenance dose if side effects appear. For what those side effects feel like and when they tend to hit, see our GLP-1 side-effect timeline, and for how weight loss tracks against the schedule, our semaglutide results timeline.

Sources

Common questions

Why do GLP-1 drugs start at a low dose and increase slowly?
The dose is escalated gradually — typically holding each level for about four weeks — to reduce gastrointestinal side effects like nausea, vomiting and diarrhea. The starting dose is a tolerability dose, not a treatment dose; the therapeutic effect builds at the higher maintenance doses reached after the titration period.
How long does it take to reach the full GLP-1 dose?
For the weight-management injectables it generally takes about 16–20 weeks of stepwise increases to reach the maintenance or maximum dose. Schedules vary by drug and your prescriber may move slower if side effects occur. Always follow the schedule your clinician sets, not a generic chart.
Are these schedules the same for diabetes and weight loss?
No. The same molecule is titrated to different targets depending on the brand and indication — for example semaglutide reaches 2.4 mg as Wegovy for weight management but is typically targeted to 0.5–2.0 mg as Ozempic for type-2 diabetes. The ladders here are shown per brand.